Evidence shows that opioid manufacturers fund patient advocacy groups in Canada, distorting policies to protect public health.
Research shows that THC and CBD in cannabis have potential to interrupt the vicious cycle of opioid addiction, dependence, withdrawal and relapse.
Cannabis legalization in Canada is a public health strategy. Let's harness this opportunity to understand how cannabis could fit into a multi-faceted opioid prevention and response strategy.
Prescription drugs are policed by industry and Health Canada has never prosecuted a drug company for illegally marketing a drug.
Research shows that exercise offers promise -- as an alternative to prescription opioids -- for relieving chronic pain.
Catastrophic increases in opioid overdose deaths across Canada require a broad response -- tackling housing, food and income insecurity as well as the contaminated drug supply.
Surgeons are big prescribers of opioids. But while guidelines are in place for dentists and for doctors who prescribe opioid-based painkillers for long-term pain, there are none for surgeons.
Opioids kill an average of eight people every day in Canada. The federal government must officially declare this a 'public welfare emergency' and invest the funds critical to a humane response.
High fructose corn syrup in food and drinks has long been linked to rising rates of child and teen obesity. New evidence suggests it increases the risks of opioid addiction and overdose too.
As Canada moves towards legalization of cannabis in 2018, there is growing evidence of the drug's potential to treat opioid addiction itself, as well as the chronic pain that often drives it.
Most physicians are unaware of effective approaches to treat opioid addiction. Addiction medicine fellowships offer a new and effective way to save lives.
One in five Canadians suffers chronic pain and almost 2,500 died last year from opioid overdose. A National Pain Strategy promises to tackle both problems.